(Q35290406)

7 August 2017

title

Suppressing miRNA-15a/-16 expression by interleukin-6 enhances drug-resistance in myeloma cells (English)

1 reference

7 August 2017

Mu Hao

1

1 reference

7 August 2017

Li Zhang

2

1 reference

7 August 2017

Gang An

3

1 reference

7 August 2017

Weiwei Sui

4

1 reference

7 August 2017

Zhen Yu

5

1 reference

7 August 2017

Dehui Zou

6

1 reference

7 August 2017

Yan Xu

7

1 reference

7 August 2017

Hong Chang

8

1 reference

7 August 2017

Lugui Qiu

9

1 reference

7 August 2017

publication date

22 September 2011

1 reference

Journal of Hematology & Oncology

7 August 2017

published in

1 reference

7 August 2017

volume

4

1 reference

7 August 2017

page(s)

37

1 reference

Multiple myeloma: biology of the disease

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189173

The clinical potential of microRNAs

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189173

Applying mass spectrometry based proteomic technology to advance the understanding of multiple myeloma.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189173

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189173

Mechanism of action of lenalidomide in hematological malignancies

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189173

MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189173

MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189173

Focus on multiple myeloma

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189173

A phase 2 study of bortezomib in relapsed, refractory myeloma

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189173

Interleukin-6 prevents dexamethasone-induced myeloma cell death.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189173

12 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-4-37

Clinical and biologic implications of recurrent genomic aberrations in myeloma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1756-8722-4-37

21 January 2018

Identifiers

DOI

10.1186/1756-8722-4-37

1 reference

Dimensions Publication ID

7 August 2017

0 references

1 reference

7 August 2017

1 reference